Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$114.17 - $185.35 $1,484 - $2,409
-13 Reduced 12.26%
93 $16,000
Q3 2023

Nov 13, 2023

BUY
$138.78 - $176.51 $416 - $529
3 Added 2.91%
106 $16,000
Q2 2023

Aug 08, 2023

SELL
$138.42 - $180.31 $1,522 - $1,983
-11 Reduced 9.65%
103 $14,000
Q1 2023

May 04, 2023

SELL
$154.26 - $198.1 $1,079 - $1,386
-7 Reduced 5.79%
114 $19,000
Q4 2022

Feb 06, 2023

BUY
$162.42 - $220.56 $3,735 - $5,072
23 Added 23.47%
121 $20,000
Q3 2022

Nov 09, 2022

SELL
$160.42 - $256.21 $2,566 - $4,099
-16 Reduced 14.04%
98 $18,000
Q2 2022

Aug 04, 2022

BUY
$140.68 - $188.02 $140 - $188
1 Added 0.88%
114 $19,000
Q1 2022

Aug 23, 2022

BUY
$161.19 - $257.96 $967 - $1,547
6 Added 5.61%
113 $21,000
Q1 2022

Apr 14, 2022

BUY
$161.19 - $257.96 $3,062 - $4,901
19 Added 21.59%
107 $20,000
Q4 2021

Feb 14, 2022

BUY
$247.59 - $304.47 $1,733 - $2,131
7 Added 8.64%
88 $23,000
Q3 2021

Nov 10, 2021

BUY
$194.77 - $324.21 $389 - $648
2 Added 2.53%
81 $23,000
Q2 2021

Aug 04, 2021

BUY
$165.87 - $220.95 $331 - $441
2 Added 2.6%
79 $16,000
Q1 2021

May 05, 2021

SELL
$180.37 - $226.26 $1,442 - $1,810
-8 Reduced 9.41%
77 $15,000
Q4 2020

Feb 04, 2021

BUY
$148.08 - $206.57 $4,294 - $5,990
29 Added 51.79%
85 $16,000
Q3 2020

Nov 09, 2020

BUY
$122.51 - $158.27 $6,860 - $8,863
56 New
56 $8,000
Q4 2019

Feb 07, 2020

SELL
$73.84 - $93.08 $221 - $279
-3 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$54.2 - $85.95 $216 - $343
-4 Reduced 57.14%
3 $0
Q1 2019

May 10, 2019

BUY
$49.45 - $62.8 $346 - $439
7 New
7 $0
Q4 2018

Feb 06, 2019

SELL
$48.26 - $68.88 $386 - $551
-8 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$32.53 - $38.92 $260 - $311
8
8 $0

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.94B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.